Background: Mortality in cardiogenic shock (CS) remains high. Significant inter-hospital heterogeneity in critical care therapies have been described, which reflects the lack of high-quality evidence to guide optimal treatment. We aimed to describe differences in practices and clinical outcomes among patients with CS in the United States (US) and Canada.
View Article and Find Full Text PDFBackground: The objective of this study was to assess the health outcomes for patients who present to the emergency department (ED) with cardiac chest pain after the implementation of an accelerated diagnostic protocol using a high-sensitivity troponin assay (hs-TnI).
Methods: This prospective before-after cohort study used population-based linked health administrative data for adult patients who presented to a Canadian urban ED with chest pain of suspected cardiac origin over a 2-year study period. The primary outcome was ED length of stay (LOS).
Eur Heart J Acute Cardiovasc Care
December 2024
Endurance-trained athletes exhibit a greater diffusing capacity for carbon monoxide (DLCO) at rest and during exercise as compared with untrained individuals; however, the mechanism(s) are unclear. The supine position translocates blood centrally and can be used to investigate DLCO responses independent of metabolic rate. We hypothesized that endurance-trained individuals would have a greater DLCO response to postural change at rest as compared with untrained and that the supine position would elicit a greater DLCO response as compared with the upright position during exercise in both groups.
View Article and Find Full Text PDFEur Heart J Acute Cardiovasc Care
December 2024
Eur Heart J Acute Cardiovasc Care
December 2024
Background: Cardiogenic shock remains highly associated with early mortality, with mortality often exceeding 50%. We sought to determine the association between prognostic factors and in-hospital and 30-day mortality in cardiogenic shock.
Methods: We performed a systematic review and meta-analysis of prognostic factors in cardiogenic shock, searching MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials for records up to June 5, 2023.
Eur Heart J Acute Cardiovasc Care
October 2024
Eur Heart J Acute Cardiovasc Care
September 2024
Eur Heart J Acute Cardiovasc Care
October 2024
Background: Cardiogenic shock due to acute myocardial infarction (AMI-CS) is associated with significant short- and long-term morbidity and mortality. Despite this, little is known about associated cost.
Objectives: The purpose of this study was to evaluate the health care costs and resource use associated with AMI-CS using administrative data from the province of Ontario, Canada.